TB Drug Access Plan Moves On Amid Concerns From Health Advocates
Executive Summary
The creators of a proposed new mechanism for stimulating R&D into new medicines for tuberculosis have replied to a number of concerns raised by health and market access advocates who say the model might serve to perpetuate the existing “flawed” funding model in lower income countries.